Skip to main content
Erschienen in: Heart Failure Reviews 3/2013

01.05.2013

Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis

verfasst von: Arsen D. Ristić, Sabine Pankuweit, Ružica Maksimović, Rainer Moosdorf, Bernhard Maisch

Erschienen in: Heart Failure Reviews | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Pericardial cytokine patterns in various diseases are not well established. We have analyzed pericardial proinflammatory (interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha) and immunoregulatory cytokines (transforming growth factor (TGF)-beta1 and interferon (IFN)-gamma) in patients with pericarditis, myocarditis, and ischemic heart disease. Pericardial fluid was obtained in 30 subsequent patients undergoing pericardiocentesis (Group 1: 60 % males, 52.4 ± 14.2 years) and in 21 patients during aortocoronary bypass surgery (Group 2: 42.9 % males, age 67.2 ± 7.4 years). After clinical, laboratory, echocardiography examination, fiberoptic pericardioscopy (Storz-AF1101Bl, Germany) and pericardial/epicardial biopsy Group 1 was subdivided to 40 % neoplastic, 36.6 % autoreactive, 10 % iatrogenic, and 13.3 % viral pericarditis. Samples were promptly aliquoted, frozen, and stored at −70 °C. The cytokines were estimated using quantikine enzyme amplified-sensitivity immuno-assays (R&D Systems, USA) and the results compared between neoplastic, viral, iatrogenic, and autoreactive pericarditis and surgical groups. IL-6 was significantly increased in PE versus serum in all forms of pericarditis (except in autoreactive) and increased in comparison with pericardial fluid of surgical patients. TNF-alpha was increased only in PE of patients with viral pericarditis in comparison with Group 2. TGF-beta1 was strikingly lower in the PE than in the serum of all pericarditis patients. However, TGF-beta1 levels in PE were significantly higher in Group 1 than in Group 2, except in viral pericarditis. IFN-gamma levels did not significantly differ between PE and serum or in comparison with Group 2. The cytokine pattern “high TNF-alpha/low TGF-beta1” was found in viral pericarditis and low IL-6 in autoreactive PE. Different etiologies of pericardial inflammation did not influence the IFN-gamma levels. IL-6 pericardial to serum ratio was significantly higher in autoreactive PE than in viral and neoplastic forms. However, TNF-alpha and IFN-gamma pericardial to serum ratios were significantly higher in viral than in autoreactive and neoplastic PE.
Literatur
2.
Zurück zum Zitat Pankuweit S, Wadlich A, Meyer E, Portig I, Hufnagel G, Maisch B (2000) Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 25:748–754PubMedCrossRef Pankuweit S, Wadlich A, Meyer E, Portig I, Hufnagel G, Maisch B (2000) Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 25:748–754PubMedCrossRef
3.
Zurück zum Zitat Maisch B, Ristić AD, Pankuweit S, Seferović PM, Spodick DH (2000) Intrapericardial treatment of autoreactive myopericarditis with triamcinolone: successful administration in patients with minimal pericardial effusion. Herz 25:781–786PubMedCrossRef Maisch B, Ristić AD, Pankuweit S, Seferović PM, Spodick DH (2000) Intrapericardial treatment of autoreactive myopericarditis with triamcinolone: successful administration in patients with minimal pericardial effusion. Herz 25:781–786PubMedCrossRef
4.
Zurück zum Zitat Maisch B, Ristić AD, Rupp H, Spodick DH (2001) Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88:1323–1326PubMedCrossRef Maisch B, Ristić AD, Rupp H, Spodick DH (2001) Pericardial access using the PerDUCER and flexible percutaneous pericardioscopy. Am J Cardiol 88:1323–1326PubMedCrossRef
5.
Zurück zum Zitat Karatolios K, Pankuweit S, Goettsch C, Hofbauer LC, Timmesfeld N, Al-Fakhri N, Maisch B, Schoppet M (2012) Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. Clin Biochem 45:237–242PubMedCrossRef Karatolios K, Pankuweit S, Goettsch C, Hofbauer LC, Timmesfeld N, Al-Fakhri N, Maisch B, Schoppet M (2012) Osteoprotegerin (OPG) and TNF-related apoptosis-inducing ligand (TRAIL) levels in malignant and benign pericardial effusions. Clin Biochem 45:237–242PubMedCrossRef
6.
Zurück zum Zitat Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J (1994) Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 104:48–56PubMedCrossRef Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J (1994) Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 104:48–56PubMedCrossRef
7.
Zurück zum Zitat Vila LM, Rivera del Rio JR, Rios Z, Rivera E (1999) Lymphocyte populations and cytokine concentrations in pericardial fluid from a systemic lupus erythematosus patient with cardiac tamponade. Ann Rheum Dis 58:720–721PubMedCrossRef Vila LM, Rivera del Rio JR, Rios Z, Rivera E (1999) Lymphocyte populations and cytokine concentrations in pericardial fluid from a systemic lupus erythematosus patient with cardiac tamponade. Ann Rheum Dis 58:720–721PubMedCrossRef
8.
Zurück zum Zitat Shikama N, Terano T, Hirai A (2000) A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart 83:711–712PubMedCrossRef Shikama N, Terano T, Hirai A (2000) A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart 83:711–712PubMedCrossRef
9.
Zurück zum Zitat Abe Y, Muta K, Kato S et al (1991) A high serum level of interleukin-6 in a patient with aggressive multiple myeloma. Rinsho Ketsueki 32:1458–1462PubMed Abe Y, Muta K, Kato S et al (1991) A high serum level of interleukin-6 in a patient with aggressive multiple myeloma. Rinsho Ketsueki 32:1458–1462PubMed
10.
Zurück zum Zitat Takahashi R, Ashihara E, Hirata T et al (1994) Aggressive myeloma with subcutaneous tumor and pericardial involvement. Rinsho Ketsueki 35(3):291–295PubMed Takahashi R, Ashihara E, Hirata T et al (1994) Aggressive myeloma with subcutaneous tumor and pericardial involvement. Rinsho Ketsueki 35(3):291–295PubMed
11.
Zurück zum Zitat Mistchenko AS, Maffey AF, Casal G, Kajon AE (1995) Adenoviral pericarditis: high levels of interleukin 6 in pericardial fluid. Pediatr Infect Dis J 14:1007–1009PubMedCrossRef Mistchenko AS, Maffey AF, Casal G, Kajon AE (1995) Adenoviral pericarditis: high levels of interleukin 6 in pericardial fluid. Pediatr Infect Dis J 14:1007–1009PubMedCrossRef
12.
Zurück zum Zitat Nakayama R, Yoneyama T, Takatani O, Kimura K (1996) A study of metastatic tumors to the heart, pericardium and great vessels. Jpn Heart J 7:227–234CrossRef Nakayama R, Yoneyama T, Takatani O, Kimura K (1996) A study of metastatic tumors to the heart, pericardium and great vessels. Jpn Heart J 7:227–234CrossRef
13.
Zurück zum Zitat Reuter H, Burgess LJ, Carstens ME, Doubell AF (2006) Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. Tuberculosis (Edinb) 86:125–133CrossRef Reuter H, Burgess LJ, Carstens ME, Doubell AF (2006) Characterization of the immunological features of tuberculous pericardial effusions in HIV positive and HIV negative patients in contrast with non-tuberculous effusions. Tuberculosis (Edinb) 86:125–133CrossRef
14.
Zurück zum Zitat Ege T, Canbaz S, Yuksel V, Duran E (2003) Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. Cytokine 23:47–51PubMedCrossRef Ege T, Canbaz S, Yuksel V, Duran E (2003) Effect of pericardial fluid pro-inflammatory cytokines on hemodynamic parameters. Cytokine 23:47–51PubMedCrossRef
15.
Zurück zum Zitat Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF (2002) Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 6:439–446PubMed Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF (2002) Cytokine production in patients with tuberculous pericarditis. Int J Tuberc Lung Dis 6:439–446PubMed
16.
Zurück zum Zitat Oyama J, Shimokawa H, Morita S, Yasui H, Takeshita A (2001) Elevated interleukin-1beta in pericardial fluid of patients with ischemic heart disease. Coron Artery Dis 12:567–571PubMedCrossRef Oyama J, Shimokawa H, Morita S, Yasui H, Takeshita A (2001) Elevated interleukin-1beta in pericardial fluid of patients with ischemic heart disease. Coron Artery Dis 12:567–571PubMedCrossRef
17.
Zurück zum Zitat Ding J, Hsu FC, Harris TB et al (2009) The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 90:499–504PubMedCrossRef Ding J, Hsu FC, Harris TB et al (2009) The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 90:499–504PubMedCrossRef
18.
Zurück zum Zitat Dore P, Lelievre E, Morel F et al (1998) Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65:183–186CrossRef Dore P, Lelievre E, Morel F et al (1998) Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65:183–186CrossRef
19.
Zurück zum Zitat Hoheisel G, Izbicki G, Roth M et al (1998) Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65:183–186PubMedCrossRef Hoheisel G, Izbicki G, Roth M et al (1998) Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 65:183–186PubMedCrossRef
20.
Zurück zum Zitat Nakano T, Chahinian AP, Shinjo M et al (1998) Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 77:907–912PubMedCrossRef Nakano T, Chahinian AP, Shinjo M et al (1998) Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 77:907–912PubMedCrossRef
21.
Zurück zum Zitat Zhang GJ, Adachi I (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19:1427–1432PubMed Zhang GJ, Adachi I (1999) Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 19:1427–1432PubMed
22.
Zurück zum Zitat Yokoyama A, Maruyama M, Ito M, Kohno N, Hiwada K, Yano S (1992) Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest 102:1055–1059PubMedCrossRef Yokoyama A, Maruyama M, Ito M, Kohno N, Hiwada K, Yano S (1992) Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest 102:1055–1059PubMedCrossRef
23.
Zurück zum Zitat Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM (1997) Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 156:1515–1522PubMedCrossRef Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM (1997) Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 156:1515–1522PubMedCrossRef
24.
Zurück zum Zitat Weissflog D, Kroegel C, Luttmann W, Grahmann PR, Hasse J (1999) Leukocyte infiltration and secretion of cytokines in pleural drainage fluid after thoracic surgery: impaired cytokine response in malignancy and postoperative complications. Chest 115:1604–1610PubMedCrossRef Weissflog D, Kroegel C, Luttmann W, Grahmann PR, Hasse J (1999) Leukocyte infiltration and secretion of cytokines in pleural drainage fluid after thoracic surgery: impaired cytokine response in malignancy and postoperative complications. Chest 115:1604–1610PubMedCrossRef
25.
Zurück zum Zitat De Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL (1997) Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 112(5):1293–1297PubMedCrossRef De Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL (1997) Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 112(5):1293–1297PubMedCrossRef
26.
Zurück zum Zitat Hua CC, Chang LC, Chen YC, Chang SC (1999) Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 116:1292–1296PubMedCrossRef Hua CC, Chang LC, Chen YC, Chang SC (1999) Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 116:1292–1296PubMedCrossRef
27.
Zurück zum Zitat Maeda J, Ueki N, Ohkawa T et al (1994) Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol 98:319–322PubMedCrossRef Maeda J, Ueki N, Ohkawa T et al (1994) Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol 98:319–322PubMedCrossRef
28.
Zurück zum Zitat Ikubo A, Morisaki T, Katano M et al (1995) A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 77:27–32PubMedCrossRef Ikubo A, Morisaki T, Katano M et al (1995) A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 77:27–32PubMedCrossRef
Metadaten
Titel
Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis
verfasst von
Arsen D. Ristić
Sabine Pankuweit
Ružica Maksimović
Rainer Moosdorf
Bernhard Maisch
Publikationsdatum
01.05.2013
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 3/2013
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-012-9334-y

Weitere Artikel der Ausgabe 3/2013

Heart Failure Reviews 3/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.